The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine
- PMID: 2675135
- DOI: 10.1016/0163-7258(89)90120-4
The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine
Similar articles
-
Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.Biochem Pharmacol. 1986 Sep 15;35(18):2999-302. doi: 10.1016/0006-2952(86)90377-1. Biochem Pharmacol. 1986. PMID: 3753512 No abstract available.
-
S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.Xenobiotica. 2015;45(12):1047-53. doi: 10.3109/00498254.2015.1042538. Epub 2015 Jun 11. Xenobiotica. 2015. PMID: 26068525
-
Variation in human metabolism of S-carboxymethylcysteine.Eur J Drug Metab Pharmacokinet. 1980;5(1):49-52. doi: 10.1007/BF03189444. Eur J Drug Metab Pharmacokinet. 1980. PMID: 7389752
-
Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1213-21. doi: 10.1517/17425250903179318. Expert Opin Drug Metab Toxicol. 2009. PMID: 19653802 Review.
-
Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.Drug Metabol Drug Interact. 1988;6(3-4):253-63. doi: 10.1515/dmdi.1988.6.3-4.253. Drug Metabol Drug Interact. 1988. PMID: 3078290 Review.
Cited by
-
Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.Ann Rheum Dis. 1992 Mar;51(3):318-20. doi: 10.1136/ard.51.3.318. Ann Rheum Dis. 1992. PMID: 1575574 Free PMC article.
-
Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis.Eur J Clin Pharmacol. 1990;38(6):605-8. doi: 10.1007/BF00278590. Eur J Clin Pharmacol. 1990. PMID: 2373135
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources